Description:

NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.

Keywords:
  1. 12/30/16 12/30/16 -
  2. 2/4/17 2/4/17 -
Uploaded on:

February 4, 2017

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

General Information
Did subject complete Study Drug Treatment?
End of Treatment
If reason is `Withdrawal by Subject` please speficy follow-up allowance
Did AE result in death?

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial